Provided by Tiger Trade Technology Pte. Ltd.

Allstate

253.83
-0.7100-0.28%
Post-market: 253.830.00000.00%19:30 EDT
Volume:2.39M
Turnover:609.33M
Market Cap:64.18B
PE:5.08
High:256.94
Open:254.13
Low:253.56
Close:254.54
52wk High:277.22
52wk Low:188.08
Shares:252.86M
Float Shares:248.44M
Volume Ratio:1.60
T/O Rate:0.96%
Dividend:4.16
Dividend Rate:1.64%
EPS(TTM):49.94
EPS(LYR):38.06
ROE:46.11%
ROA:8.68%
PB:2.02
PE(LYR):6.67

Loading ...

Allstate Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 10

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

GlobeNewswire
·
Jun 10

A Look At Allstate (ALL) Valuation After Recent Share Price Pullback And Modest Undervaluation Estimate

Simply Wall St.
·
Jun 10

Allstate Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 09

Property Insurers Are Piling Into Private Assets, as Other Investors Hit Pause -- WSJ

Dow Jones
·
Jun 09

Allstate Shares Fall After Keefe Bruyette & Woods Downgrade

MT Newswires Live
·
Jun 09

Allstate Cut to Market Perform From Outperform by Keefe, Bruyette & Woods

Dow Jones
·
Jun 09

Press Release: Vaxart Urges Shareholders to Vote "FOR" ALL Six of the Company's Highly Qualified Director Nominees on the WHITE Proxy Card TODAY

Dow Jones
·
Jun 08

Keefe Bruyette & Woods Downgrades Allstate to Market Perform From Outperform, Adjusts PT to $242 From $266

MT Newswires Live
·
Jun 08

U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex

Reuters
·
Jun 08

Allstate Corp : Kbw Cuts to Market Perform From Outperform; Cuts Target Price to $242 From $266

THOMSON REUTERS
·
Jun 08

Allstate downgraded to Market Perform from Outperform at Keefe Bruyette

TIPRANKS
·
Jun 08

Barclays Sticks to Its Sell Rating for Allstate (ALL)

TIPRANKS
·
Jun 06

Allstate Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 06

Movement Alert|Allstate Rises 3.89% in Regular Trading, Trading at $219.07

Market Focus
·
Jun 06

Barclays Adjusts Price Target on Allstate to $203 From $208, Maintains Underweight Rating

MT Newswires Live
·
Jun 04

Allstate director Andrea Redmond sells 2,225 shares for $451,474.75

Reuters
·
Jun 03

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

GlobeNewswire
·
Jun 03

Allstate (ALL) Valuation Check As Recent Returns Cool And Fair Value Signals Possible Overpricing

Simply Wall St.
·
Jun 02

Allstate Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 02